Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
出版年份 2016 全文链接
标题
Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 17, Issue 4, Pages 619-626
出版商
Informa Healthcare
发表日期
2016-01-26
DOI
10.1517/14656566.2016.1146689
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ-opioid receptor occupancy
- (2016) Lars-Erik Broksoe Kyhl et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Alcohol use disorders
- (2016) Jason P Connor et al. LANCET
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis
- (2015) Kim Donoghue et al. ADDICTION
- Global statistics on addictive behaviours: 2014 status report
- (2015) Linda R. Gowing et al. ADDICTION
- A Pharmacogenetic Determinant of Mu-Opioid Receptor Antagonist Effects on Alcohol Reward and Consumption: Evidence from Humanized Mice
- (2015) Ainhoa Bilbao et al. BIOLOGICAL PSYCHIATRY
- High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial
- (2015) Christian A. Müller et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme
- (2015) Wim van den Brink et al. Expert Opinion On Drug Safety
- Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
- (2015) Michael Roerecke et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
- (2015) Matt Stevenson et al. PHARMACOECONOMICS
- Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase
- (2015) Daniel J.O. Roche et al. PSYCHONEUROENDOCRINOLOGY
- Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients
- (2015) Henri-Jean Aubin et al. EUROPEAN ADDICTION RESEARCH
- Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review
- (2015) Roberta Agabio et al. EUROPEAN ADDICTION RESEARCH
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials
- (2015) Molly Magill et al. Journal of Studies on Alcohol and Drugs
- The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients
- (2015) Clément François et al. PLoS One
- Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence
- (2014) James C. Garbutt et al. ADDICTION
- Current pharmacological treatment approaches for alcohol dependence
- (2014) Christian A Müller et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study
- (2014) Wim van den Brink et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Bad medicine: nalmefene in alcohol misuse
- (2014) D. Spence BMJ-British Medical Journal
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
- (2013) W. van den Brink et al. ALCOHOL AND ALCOHOLISM
- Naltrexone and Nalmefene: Any Meaningful Difference?
- (2013) Robert M. Swift BIOLOGICAL PSYCHIATRY
- Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology
- (2013) Jørgen Matz et al. CLINICAL DRUG INVESTIGATION
- Emerging pharmacotherapies for alcohol dependence: A systematic review focusing on reduction in consumption
- (2013) Henri-Jean Aubin et al. DRUG AND ALCOHOL DEPENDENCE
- A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
- (2013) Antoni Gual et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Nalmefene for the treatment of alcohol dependence: a current update
- (2013) Michael Soyka INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Reduction of Alcohol Consumption and Subsequent Mortality in Alcohol Use Disorders
- (2013) Michael Roerecke et al. JOURNAL OF CLINICAL PSYCHIATRY
- The role of the opioid system in alcohol dependence
- (2013) David J Nutt JOURNAL OF PSYCHOPHARMACOLOGY
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- (2013) Harvey A Whiteford et al. LANCET
- Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
- (2012) Natalya C. Maisel et al. ADDICTION
- Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis
- (2012) Antonio-Javier Chamorro et al. ADDICTION BIOLOGY
- Variation inOPRM1moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment
- (2012) Henry R. Kranzler et al. ADDICTION BIOLOGY
- Recent Advances in the Discovery and Preclinical Testing of Novel Compounds for the Prevention and/or Treatment of Alcohol Use Disorders
- (2012) Daryl L. Davies et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
- (2012) Karl Mann et al. BIOLOGICAL PSYCHIATRY
- Influence of theOPRM1A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone
- (2012) Elaine Setiawan et al. PHARMACOGENOMICS
- Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians
- (2011) Dingyan Chen et al. DRUG AND ALCOHOL DEPENDENCE
- Emerging drugs to treat alcoholism
- (2010) Michael Soyka et al. EXPERT OPINION ON EMERGING DRUGS
- In vivo characterization of the opioid antagonist nalmefene in mice
- (2010) Melissa D. Osborn et al. LIFE SCIENCES
- Compulsive alcohol drinking in rodents
- (2009) Valentina Vengeliene et al. ADDICTION BIOLOGY
- Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study
- (2009) Tim M. Williams et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
- (2009) Rainer Spanagel PHYSIOLOGICAL REVIEWS
- Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers
- (2008) Albert J. Arias et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Drugs for relapse prevention of alcoholism: ten years of progress
- (2008) Rainer Spanagel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism
- (2008) Michael Soyka et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started